Mark William Kieran

Dr. Mark William Kieran


Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1990 in Cell
Verified
Journal Article
Closed access
MKMark William Kieran
Mark William Kieran
VBVolker Blank
Volker Blank
FLFrédérique Logeat
Frédérique Logeat
JVJoël Vandekerckhove
Joël Vandekerckhove
FLFrledrich Lottspeich
Frledrich Lottspeich
AIAlain Israël
Alain Israël

30 June 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
TPthe International Cancer Genome Consortium PedBrain Tumor Project
the International Cancer Genome Consortium PedBrain Tumor Project
DJDavid T W Jones
David T W Jones
BHBarbara Hutter
Barbara Hutter
NJNatalie Jäger
Natalie Jäger
Andrey KorshunovAndrey Korshunov
Andrey Korshunov
PLPeter Lichter
Peter Lichter

1 March 2014 in Cancer Cell
Verified
Journal Article
Closed access
MKMarcel Kool
Marcel Kool
DJDavid T.W. Jones
David T.W. Jones
NJNatalie Jäger
Natalie Jäger
PNPaul A. Northcott
Paul A. Northcott
TPTrevor J Pugh
Trevor J Pugh
Stefan PfisterStefan Pfister
Stefan Pfister

20 April 2018 in Science
Verified
Journal Article
Closed access
PDF file
MFMariella G. Filbin
Mariella G. Filbin
ITItay Tirosh
Itay Tirosh
VHVolker Hovestadt
Volker Hovestadt
MSMcKenzie L. Shaw
McKenzie L. Shaw
LELeah E. Escalante
Leah E. Escalante
MSMario L. Suvà
Mario L. Suvà
The cellular composition of H3K27M gliomas: Diffuse midline gliomas with histone H3 lysine27-to-methionine mutations (H3K27M-glioma) are an aggressive type of childhood cancer with few options for treatment. Filbin et al. used a single-cell sequencing approach to study the oncogenic programs, genetics, and cellular hierarchies of H3K27M-glioma. Tumors were mainly composed of cells resembling oligodendrocyte precursor cells, whereas differentiated malignant cells were a smaller fraction. In comparison with other gliomas, these cancers had distinct oncogenic programs and stem cell–like profiles that contributed to their stable tumor-propagating potential. The analysis also identified a lineage-specific marker that may be useful in developing therapies. Science , this issue p. 331

31 December 2006 in Cancer Biology & Therapy
Verified
Journal Article
Closed access
HSHikaru Sugimoto
Hikaru Sugimoto
TMThomas M Mundel
Thomas M Mundel
MKMark William Kieran
Mark William Kieran
RKRaghu Kalluri
Raghu Kalluri
Tumors are unorganized organs that contain many different cell types. In the recent years, many studies have reported that primary tumors contain fibroblasts/myofibroblasts (carcinoma-associated fi...

11 May 2014 in Nature Nanotechnology
Verified
Journal Article
Open access
PDF file
JDJames E. Dahlman
James E. Dahlman
CBCarmen Barnes
Carmen Barnes
OKOmar F. Khan
Omar F. Khan
ATAude Thiriot
Aude Thiriot
SJSiddharth Jhunjunwala
Siddharth Jhunjunwala
DADaniel G. Anderson
Daniel G. Anderson
Dysfunctional endothelium contributes to more diseases than any other tissue in the body. Small interfering RNAs (siRNAs) can help in the study and treatment of endothelial cells in vivo by durably silencing multiple genes simultaneously, but efficient siRNA delivery has so far remained challenging. Here, we show that polymeric nanoparticles made of low-molecular-weight polyamines and lipids can deliver siRNA to endothelial cells with high efficiency, thereby facilitating the simultaneous silencing of multiple endothelial genes in vivo. Unlike lipid or lipid-like nanoparticles, this formulation does not significantly reduce gene expression in hepatocytes or immune cells even at the dosage necessary for endothelial gene silencing. These nanoparticles mediate the most durable non-liver silencing reported so far and facilitate the delivery of siRNAs that modify endothelial function in mouse models of vascular permeability, emphysema, primary tumour growth and metastasis.